2
Orphan Designations
0
FDA Approvals
2
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| acute lymphoblastic leukemia | Fully Human CD19 / CD22 Dual Target Chimeric Antigen Receptor Autologous T Cell Injection | Orphan Designation | - |
| plasma cell myeloma | Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A) | Orphan Designation | - |